Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes.

Xiaohua Jiang, Lauren A Fielding, Hunter Davis, William Carroll, Edward C Lisic, Joseph E Deweese

Journal: International journal of molecular sciences 2023;24(15):12010

PMID: 37569386

Abstract

Topoisomerases, common targets for anti-cancer therapeutics, are crucial enzymes for DNA replication, transcription, and many other aspects of DNA metabolism. The potential anti-cancer effects of thiosemicarbazones (TSC) and metal-TSC complexes have been demonstrated to target several biological processes, including DNA metabolism. Human topoisomerases were discovered among the molecular targets for TSCs, and metal-chelated TSCs specifically displayed significant inhibition of topoisomerase II. The processes by which metal-TSCs or TSCs inhibit topoisomerases are still being studied. In this brief review, we summarize the TSCs and metal-TSCs that inhibit various types of human topoisomerases, and we note some of the key unanswered questions regarding this interesting class of diverse compounds.

Address: Department of Chemistry, Vanderbilt University, Nashville, TN 37240, USA.; Department of Biological, Physical and Human Sciences, Freed Hardeman University, Henderson, TN 38340, USA.; Department of Chemistry, Tennessee Tech University, Cookeville, TN 38505, USA.; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37240, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.